Global research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025)

This study represents the first bibliometric analysis of biomarkers in lung cancer immunotherapy. Through scientometric visualization tools, our analysis delineates a paradigm shift from reductionist biomarker discovery to multidimensional integration and translational validation. Prospective advancements necessitate leveraging technological innovations, fostering international collaborative networks, and promoting multi-omics convergence. These efforts aim to facilitate a critical transition from population-based therapeutic strategies to precision-driven stratification, ultimately optimizing clinical outcomes and survival benefits for heterogeneous patient populations.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-02-03
DOI
https://doi.org/10.3389/fimmu.2026.1622573
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025)

Jun He, Chaoying Liu, Yiguang Zhou, Fang Ma et al.
Frontiers in Immunology
Cancer Immunotherapy and Biomarkers
article

Global research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025)

Jun He, Chaoying Liu, Yiguang Zhou, Fang Ma, Xianling Liu
article en

Abstract

This study represents the first bibliometric analysis of biomarkers in lung cancer immunotherapy. Through scientometric visualization tools, our analysis delineates a paradigm shift from reductionist biomarker discovery to multidimensional integration and translational validation. Prospective advancements necessitate leveraging technological innovations, fostering international collaborative networks, and promoting multi-omics convergence. These efforts aim to facilitate a critical transition from population-based therapeutic strategies to precision-driven stratification, ultimately optimizing clinical outcomes and survival benefits for heterogeneous patient populations.

Frontiers in ImmunologyVol. 17
Central South University (CN), Second Xiangya Hospital of Central South University (CN)
Openalex Percentile: Top 70%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.